A patient developed neuroleptic malignant syndrome after a single dose of v
enlafaxine with trifluoperazine treatment. A dopamine-inhibition effect ind
uced by one dose of venlafaxine may have augmented dopamine-receptor inhibi
tion by trifluoperazine.